<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Progressive-Pulmonary-Fibrosis on Rheumatology Digest</title><link>https://rheumatologydigest.org/tags/progressive-pulmonary-fibrosis/</link><description>Recent content in Progressive-Pulmonary-Fibrosis on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Fri, 09 Oct 2026 05:00:00 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/tags/progressive-pulmonary-fibrosis/index.xml" rel="self" type="application/rss+xml"/><item><title>Nerandomilast in Autoimmune ILD: FIBRONEER-ILD</title><link>https://rheumatologydigest.org/posts/nerandomilast-autoimmune-ppf/</link><pubDate>Fri, 09 Oct 2026 05:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/nerandomilast-autoimmune-ppf/</guid><description>Nerandomilast slowed FVC decline and cut exacerbation, hospitalisation or death in autoimmune PPF — but this is a subgroup, and FVC intervals crossed zero.</description></item></channel></rss>